ICECURE MEDICAL LTD (ICCM) Stock Income Statement
NASDAQ:ICCM - Nasdaq - IL0011224156 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.27M | 3.29M | 3.23M | 3.09M | 4.14M | |||
| Cost Of Goods | 1.87M | 1.84M | 1.93M | 1.64M | 1.94M | |||
| Gross Profit | 1.40M | 1.45M | 1.30M | 1.45M | 2.20M | |||
| Operating Expenses | 17.10M | 17.15M | 16.88M | 18.18M | 11.92M | |||
| Research and Development | 6.81M | 7.10M | 8.27M | 9.12M | 5.88M | |||
| Selling, General, and Administrative Expenses | 10.29M | 10.05M | 8.60M | 9.06M | 6.04M | |||
| Operating Income | -15.70M | -15.70M | -15.58M | -16.74M | -9.72M | |||
| Interest Income/Expense | 406.00K | 378.00K | 924.00K | -240.00K | -170.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -15.30M | -15.32M | -14.65M | -16.98M | -9.90M | |||
| Net Income | -15.30M | -15.32M | -14.65M | -16.98M | -9.90M | |||
| EBITDA | -15.37M | -15.36M | -15.25M | -16.49M | -9.59M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.29 | -0.30 | -0.32 | -0.46 | -0.35 | |||
| Non GAAP EPS | -0.28 | -0.30 | -0.31 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 42.77% | 44.09% | 40.26% | 46.93% | 53.14% | |||
| Profit Margin | -467.37% | -465.45% | -453.76% | -549.51% | -239.13% | |||
| Operating Profit Margin | -479.77% | -476.94% | -482.38% | -541.75% | -234.78% | |||
All data in USD